Regenerative Medicine is More Than Just Stem Cell Research as R&D Activities of Key Players Have Proven

Oct 04, 2016, 08:30 ET from Market Data Forecast

HYDERABAD, India, October 4, 2016 /PRNewswire/ --

According to the report "Regenerative Medicines Market", published by Market Data Forecast, the global market is projected to reach USD 48.90 billion by 2021, at a CAGR of 23.24% from 2016 to 2021.

     (Logo: )

For full report refer to ""

Regenerative medicines repair, replace or regenerate human cells, tissues, or organs affected due to injury, disease, aging processes, congenital defects, and damage due to trauma. These medicines restore normal functions of cells & tissues. These medicines are available in different types such as genes, somatic cells, stem cells, and other types. Some of these medicines (such as stem cells) have the ability to proliferate, differentiate thereby restore the original structure of cells or tissues or organs. Regenerative medicines are used in varied range of degenerative disorders include cardiovascular, neurodegenerative diseases, dermatology, and orthopedic, among others. Majority of the researchers aim to focus on the development of innovative technologies to provide better regenerative medicines and effective healthcare treatment solutions to patients.

Free sample for the report is available at ""

Global regenerative medicines market is expected to witness growth owing to rising demand for biologically derived materials for regenerative medicine, growing technological advancements (nanotechnology based tissue engineering), and high support from government to promote the tissue engineering for the development of advanced therapies. In addition, growing utilization of regenerative medicines in cancer research & drug discovery, increasing organ transplantations, and rising healthcare expenditure are further stimulating the growth of global regenerative medicines market.

Buy the full report at ""

Global market for regenerative medicines is segmented on the basis of product, therapy, and application

On the basis of Product 

  • Cell-Based products
  • Autologous Cell-Based Products
  • Allogeneic Cell-Based Products
  • Acellular Products

On the basis of Therapy 

  • Cell Therapy
  • Gene Therapy
  • Tissue Engineering
  • Immunotherapy

On the basis of Application 

  • Orthopedic & Musculoskeletal Spine
  • Dermatology
  • Cardiovascular
  • Central Nervous System
  • Oncology
  • Diabetes
  • Other Applications

On the basis of Geography 

The key players in global regenerative medicines market such as, Vertex Pharmaceuticals Incorporated (U.S.), Acelity L.P. Inc. (U.S.), Celgene Corporation (U.S.), StemCells, Inc. (U.S.), Organogenesis Inc. (U.S.), NuVasive, Inc. (U.S.), Vericel Corporation (Genzyme) (U.S.), Japan Tissue Engineering Co., Ltd. (Japan), Cytori Therapeutics Inc. (U.S.), Advantagene, Inc. (U.S.), and Mesoblast Ltd. (Australia).

The Regenerative Medicine Market Study provides you with: 

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter's five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

Checkout other related studies in the Medical Devices Segment: 

Hemophilia Management Market:

Nuclear Medicine Radiopharmaceuticals Market:

Pharmaceutical Excipients Market:

Plasma Protein Therapeutics Market:

Preventive Vaccines Market:

About Us: 

Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.

Abhishek Shukla
Team Lead (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206

Visit MarketDataForecast Blog @

View latest Press Releases of MDF @

SOURCE Market Data Forecast